成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>protein tyrosine kinase>Lenvatinib Mesylate
Lenvatinib Mesylate
  • Lenvatinib Mesylate
  • Lenvatinib Mesylate
  • Lenvatinib Mesylate
  • Lenvatinib Mesylate
  • Lenvatinib Mesylate

Lenvatinib Mesylate NEW

Price Get Latest Price
Package 1kg
Min. Order: 1kg
Supply Ability: 10000kg
Update Time: 2024-05-07

Product Details

Product Name: Lenvatinib Mesylate CAS No.: 857890-39-2
EC-No.: 812-398-0 Min. Order: 1kg
Purity: 99% Supply Ability: 10000kg
Release date: 2024/05/07

Factory Provide High Quality Antiretroviral Efavirenz Powder CAS 154598-52-4 Efavirenz


Article illustration

Introduction

Product Name : Lenvatinib Mesylate

Other name: lenvatinib Methanesulfonate;E7080 Mesylate;4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate;

CAS No.: 857890-39-2

Molecular Formula: C22H23ClN4O7S

Article illustration

Molecular Weight: 522.95862

Specification:99%

Appearance: White powder or crystal 

Melting Point :>220°C (dec.) (rough estimate)

Storage :Keep in dark place,Sealed in dry,Store in freezer, under -20°C


Lenvatinib Mesylate is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well.
Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).


Application

Lenvatinib Mesylate is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well.
It is currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
It is currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
Article illustration



Company Profile Introduction

Shaanxi TNJONE Pharmaceutical Co., Ltd supplies more than 2,000 kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, food additives, natural nutrition ingredients, feed additives, cosmetic additives, intermediates etc. With global sourcing advantages, the group is fully capable of meeting the one-stop sourcing needs of global customers. Today, Shaanxi TNJONE Pharmaceutical Co., Ltd.'s marketing network has spread over more than 100 countries and regions on five continents, providing professional service for global customers.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$34.00/10mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-18
$5.00/1KG
VIP4Y
Hebei Chuanghai Biotechnology Co,.LTD
2024-08-21
$0.00/1kg
VIP1Y
Fuzhou Lista Biotechnology Co.,Ltd
2024-07-26
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-07-24
$1.00/1g
VIP1Y
Apeloa production Co.,Limited
2024-06-19
$0.00/1kg
Nanjing Fred Technology Co., Ltd
2023-12-19
$1.00/1kg
VIP2Y
Jinan Million Pharmaceutical Co., Ltd
2023-12-11
$100.00/1kg
VIP2Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-11-20
$0.00/1Kg/Bag
VIP4Y
Sinoway Industrial co., ltd.
2023-11-14
$0.00/10gkg
VIP2Y
shan dong Fengjin Pharmaceutical company
2023-09-20

Shaanxi TNJONE Pharmaceutical Co., Ltd

1YR ChinaChina
  • Since: 2019-05-23
  • Address: No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New C
INQUIRY